the acute electrophysiologic effects and therapeutic efficacy of intravenous and oral flecainide were assessed in 18 patients with recurrent supraventricular tachyarrhythmias , resistant to conventional antiarrhythmic agents .
C0016229
flecainide
C0003195
antiarrhythmic agents